BeiGene Ltd (HK:6160) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
BeiGene, Ltd., a biotechnology company, has released an overseas regulatory announcement detailing its Form 8-K filing with the U.S. Securities and Exchange Commission. This filing is significant for investors tracking BeiGene’s activities on global stock exchanges, as it outlines the company’s current financial and operational status. Investors should note that BeiGene’s American Depositary Shares are traded on NASDAQ, while its ordinary shares trade on the Hong Kong Stock Exchange.
For further insights into HK:6160 stock, check out TipRanks’ Stock Analysis page.